The success of Chimeric Antigen Receptor (CAR) T-cell technology in targeting hematologic malignancies has established a robust blueprint for synthetic immunology. However, for researchers in the fields of molecular biology and cellular engineering, the current frontier lies in the repurposing of this modular platform for non-malignant indications. By decoupling the CAR structure from simple...

In the field of molecular biology, the ability to introduce exogenous genetic material into specific cell types is a fundamental requirement for functional genomics and biochemical analysis. While traditional chemical transfection methods often fall short in primary cells or complex in vivo models, recombinant viral vectors have emerged as the gold standard for high-efficiency gene...

That simple statement captures why glycoproteins have become one of the most compelling frontiers in biomedical research. These sugar‑coated proteins are not passive ornaments; they are active messengers, shaping how cells talk, how the immune system responds, and how diseases unfold.   When Sugar Codes Go Wrong Glycosylation in health and disease represents one of the most...

Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs.   Functional Target Screening: Moving Beyond Binding Traditional phage display often...

For years, bioconjugation was treated as a supporting technique—important, yes, but rarely the centerpiece of scientific discussion. That era is ending. As drug developers push toward more targeted, multifunctional, and tunable biomolecules, bioconjugation has moved from the periphery to the strategic core of modern biomedicine. The shift is not just technical; it reflects a broader...

In the race to bring new therapies to patients, one challenge consistently stands out: drug delivery. Discovering powerful molecules is only half the battle; ensuring they reach the right cells safely and effectively is equally critical. Lipid-based drug delivery systems are emerging as one of the most versatile solutions, offering improved solubility, stability, and bioavailability for...